Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations-Reference-Cited by-同舟云学术

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations

Published:2015-09 Issue:9 Volume:21 Page:1023-1030
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Trenkwalder Claudia,Chaudhuri K. Ray,García Ruiz Pedro J.,LeWitt Peter,Katzenschlager Regina,Sixel-Döring Friederike,Henriksen Tove,Sesar Ángel,Poewe Werner,Baker Mary,Ceballos-Baumann Andres,Deuschl Günther,Drapier Sophie,Ebersbach Georg,Evans Andrew,Fernandez Hubert,Isaacson Stuart,van Laar Teus,Lees Andrew,Lewis Simon,Martínez Castrillo Juan Carlos,Martinez-Martin Pablo,Odin Per,O'Sullivan John,Tagaris Georgios,Wenzel Karoline

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference39 articles.

1. Apomorphine in Parkinson's disease;Schwab;Trans. Am. Neurol. Assoc.,1951

2. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease

3. A reassessment of risks and benefits of dopamine agonists in Parkinson's disease;Antonini;Lancet Neurol.,2009

4. The movement disorder society evidence-based medicine review update: treatments for the motor symptoms of Parkinson's disease;Fox;Mov. Disord.,2011

5. Apokyn for Morning Akinesia Trial (AM IMPAKT);Isaacson,2013

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

2. Influence of continuous subcutaneous apomorphine infusion on cognition and behavior in Parkinson's disease: A systematic review;Revue Neurologique;2024-08

3. Effectiveness of Continuous Dopaminergic Therapies in Parkinson’s Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics;Journal of Parkinson's Disease;2024-07-23

4. What was first and what is next in selecting device-aided therapy in Parkinson’s disease? Balancing evidence and experience;Journal of Neural Transmission;2024-05-15

5. Advanced therapies in Parkinson’s disease: an individualized approach to their indication;Journal of Neural Transmission;2024-04-13